SAN ANTONIO--(BUSINESS WIRE)--Kinetic Concepts, Inc. (NYSE:KCI), a global medical technology company with leadership positions in advanced wound care and therapeutic surfaces, today announced that it has filed a notice of appeal with the U.S. District Court for the Western District of Texas in its patent infringement litigation against BlueSky Medical Group, Inc., Medela AG, and related parties. The patents at issue are licensed by KCI from Wake Forest University and relate to KCI’s V.A.C.® technology, which is used for the treatment of patients with serious, complex wounds. The trial court found the patents to be valid and enforceable, but not infringed. The appeal will be heard by the U.S. Federal Circuit Court in Washington D.C., though no schedule for the appeal process has been established.
